# Evaluate Saxagliptin in Adult Indian Patients With Type 2 Diabetes Inadequate Glycemic Control

> **NCT00918879** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 213 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Saxagliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00918879
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2011-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00918879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00918879, "Evaluate Saxagliptin in Adult Indian Patients With Type 2 Diabetes Inadequate Glycemic Control". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00918879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*